CEO, Reckitt Benckiser
Laxman became CEO of RB, a FTSE 15 company, in September 2019. As a global leader in Health, Hygiene and Nutrition, RB’s brands are found in more than 190 countries. It has annual revenues of approximately £13BN and employs 42,000 colleagues globally
20 million times a day RB brands are selected by consumers, who rely on the company’s 200-year strong heritage. This stable of trusted global brands includes: Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Woolite, Air Wick and more.
Under Laxman’s leadership, RB’s purpose is to protect, heal and nurture in a relentless pursuit of a cleaner, healthier world. RB fights to make access to the highest-quality hygiene, wellness and nourishment a right, not a privilege, for everyone.
Prior to joining the company, Laxman held various roles at PepsiCo from 2012 to 2019. He was previously Global Chief Commercial Officer, with responsibility for R&D, categories, e-commerce, design, go-to-market, global customers and strategy.
Before this, Laxman served as the Chief Executive Officer of PepsiCo’s Latin America, Europe and Sub-Saharan Africa operations, where he ran the company's food and beverage businesses across over 100 countries. He also spent time as CEO of PepsiCo Latin America and as the CFO of PepsiCo Americas Foods, which was responsible for half of the company’s profits.
Prior to PepsiCo, Laxman served as a Director for McKinsey & Company and held various key global roles from 1993 to 2012. He is a Trustee of the Brookings Institution and a member of the Council on Foreign Relations.